Composition
- Active ingredients
- DURLOBACTAM SODIUM EQ 500MG BASE/VIAL; DURLOBACTAM SODIUM EQ 500MG BASE/VIAL; SULBACTAM SODIUM EQ 1GM BASE/VIAL
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA216974.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Xacduro (Copackaged)
- Active substance
- durlobactam sodium
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Entasis Therap
- Status
- Prescription
- FDA approval
- 23 May 2023
- Application
- NDA216974-001